日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Antitumor efficacy of intermittent low-dose erlotinib plus sulindac via MHC upregulation and remodeling of the immune cell niche.

间歇性低剂量厄洛替尼联合舒林酸通过上调 MHC 和重塑免疫细胞微环境发挥抗肿瘤疗效

期刊:International Journal of Cancer
影响因子:4.7
doi:10.1002/ijc.35409
Tripathi Chakrapani, Tovar Perez Jorge E, Kapoor Sabeeta, Muhsin Ahmed, Dashwood Wan Mohaiza, Demirhan Yunus, Demirhan Melek, Shapiro Alessandro, Mohammed Altaf, Sei Shizuko, Thompson Jacklyn, Zaheer Mahira, Sinha Krishna M, Brown Powel H, Savage Michelle I, Vilar Eduardo, Rajendran Praveen, Dashwood Roderick H
细胞生物学
肿瘤
肿瘤免疫
发表日期：2025
文献求助 收藏

Development of Primary Colon and Duodenal Tumor Cultures from the Apc-mutant Pirc Rat for Screening Preventive Agents

利用Apc突变Pirc大鼠建立原发性结肠和十二指肠肿瘤培养模型以筛选预防药物

期刊:Journal of Cancer Prevention
影响因子:1.8
doi:10.15430/JCP.25.016
Muhsin, Ahmed; Neja, Sultan; Mohan, Nivedhitha; Kapoor, Sabeeta; Perez, Jorge Enrique Tovar; Dashwood, Wan-Mohaiza; Rashid, Asif; Dashwood, Roderick; Rajendran, Praveen
肿瘤
Rat
肿瘤免疫
发表日期：2025
文献求助 收藏

Epigenetic regulation of major histocompatibility complexes in gastrointestinal malignancies and the potential for clinical interception

胃肠道恶性肿瘤中主要组织相容性复合体的表观遗传调控及其临床干预潜力

期刊:Clinical Epigenetics
影响因子:4.4
doi:10.1186/s13148-024-01698-8
Tovar Perez, Jorge Enrique; Zhang, Shilan; Hodgeman, William; Kapoor, Sabeeta; Rajendran, Praveen; Kobayashi, Koichi S; Dashwood, Roderick H
信号转导
肿瘤
表观遗传
肿瘤免疫
发表日期：2024
文献求助 收藏

Optimization of Erlotinib Plus Sulindac Dosing Regimens for Intestinal Cancer Prevention in an Apc-Mutant Model of Familial Adenomatous Polyposis (FAP)

在家族性腺瘤性息肉病（FAP）Apc突变模型中优化厄洛替尼联合舒林酸给药方案以预防肠癌

期刊:Cancer Prevention Research
影响因子:2.6
doi:10.1158/1940-6207.CAPR-20-0262
Ulusan, Ahmet M; Rajendran, Praveen; Dashwood, Wan Mohaiza; Yavuz, Omer F; Kapoor, Sabeeta; Gustafson, Trace A; Savage, Michelle I; Brown, Powel H; Sei, Shizuko; Mohammed, Altaf; Vilar, Eduardo; Dashwood, Roderick H
肿瘤
肠癌
肿瘤免疫
FAP
免疫/内分泌
发表日期：2021
文献求助 收藏